Tang Y, Zhang J, Fang Y, Zhu K, Zhu J, Huang C
Nat Cardiovasc Res. 2025; 4(2):235-247.
PMID: 39809927
DOI: 10.1038/s44161-024-00603-z.
Paraskevaidis I, Kourek C, Farmakis D, Tsougos E
Biomolecules. 2025; 14(12.
PMID: 39766241
PMC: 11673776.
DOI: 10.3390/biom14121534.
Szabo L, Lejri I, Grimm A, Eckert A
Antioxidants (Basel). 2025; 13(12.
PMID: 39765811
PMC: 11673406.
DOI: 10.3390/antiox13121482.
Tabara L, Segawa M, Prudent J
Nat Rev Mol Cell Biol. 2024; 26(2):123-146.
PMID: 39420231
DOI: 10.1038/s41580-024-00785-1.
Li J, Yang Z, Song H, Yang L, Na K, Mei Z
iScience. 2024; 27(9):110809.
PMID: 39290834
PMC: 11406077.
DOI: 10.1016/j.isci.2024.110809.
Sensory-Motor Neuropathy in Mfn2 T105M Knock-in Mice and Its Reversal by a Novel Piperine-Derived Mitofusin Activator.
Weigele J, Zhang L, Franco A, Cartier E, Dorn 2nd G
J Pharmacol Exp Ther. 2024; 391(2):361-374.
PMID: 39284622
PMC: 11493442.
DOI: 10.1124/jpet.124.002258.
Advances and challenges in modeling inherited peripheral neuropathies using iPSCs.
Van Lent J, Prior R, Perez Siles G, Cutrupi A, Kennerson M, Vangansewinkel T
Exp Mol Med. 2024; 56(6):1348-1364.
PMID: 38825644
PMC: 11263568.
DOI: 10.1038/s12276-024-01250-x.
Charcot-Marie-Tooth type 2A in vivo models: Current updates.
Abati E, Rizzuti M, Anastasia A, Comi G, Corti S, Rizzo F
J Cell Mol Med. 2024; 28(9):e18293.
PMID: 38722298
PMC: 11081012.
DOI: 10.1111/jcmm.18293.
Molecular mechanisms and therapeutic strategies for neuromuscular diseases.
Zambon A, Falzone Y, Bolino A, Previtali S
Cell Mol Life Sci. 2024; 81(1):198.
PMID: 38678519
PMC: 11056344.
DOI: 10.1007/s00018-024-05229-9.
Leflunomide Treatment Does Not Protect Neural Cells following Oxygen-Glucose Deprivation (OGD) In Vitro.
Curel C, Nobeli I, Thornton C
Cells. 2024; 13(7.
PMID: 38607070
PMC: 11011260.
DOI: 10.3390/cells13070631.
Metformin normalizes mitochondrial function to delay astrocyte senescence in a mouse model of Parkinson's disease through Mfn2-cGAS signaling.
Wang M, Tian T, Zhou H, Jiang S, Jiao Y, Zhu Z
J Neuroinflammation. 2024; 21(1):81.
PMID: 38566081
PMC: 10986112.
DOI: 10.1186/s12974-024-03072-0.
Fusion activators enhance mitochondrial function.
Rosencrans W, Chan D
Mitochondrial Commun. 2024; 1:33-34.
PMID: 38515999
PMC: 10956541.
DOI: 10.1016/j.mitoco.2023.03.001.
and studies on the effect of a mitochondrial fusion promoter on Leydig cell integrity and function.
Garza S, Sottas C, Gukasyan H, Papadopoulos V
Front Toxicol. 2024; 6:1357857.
PMID: 38511146
PMC: 10950900.
DOI: 10.3389/ftox.2024.1357857.
Mfn2/Hsc70 Complex Mediates the Formation of Mitochondria-Lipid Droplets Membrane Contact and Regulates Myocardial Lipid Metabolism.
Hu L, Tang D, Qi B, Guo D, Wang Y, Geng J
Adv Sci (Weinh). 2024; 11(14):e2307749.
PMID: 38311582
PMC: 11005711.
DOI: 10.1002/advs.202307749.
The role of mitochondrial dynamics in disease.
Wang Y, Dai X, Li H, Jiang H, Zhou J, Zhang S
MedComm (2020). 2023; 4(6):e462.
PMID: 38156294
PMC: 10753647.
DOI: 10.1002/mco2.462.
Novel Relationship between Mitofusin 2-Mediated Mitochondrial Hyperfusion, Metabolic Remodeling, and Glycolysis in Pulmonary Arterial Endothelial Cells.
Yegambaram M, Sun X, Flores A, Lu Q, Soto J, Richards J
Int J Mol Sci. 2023; 24(24).
PMID: 38139362
PMC: 10744129.
DOI: 10.3390/ijms242417533.
Unraveling the Intricacies of Autophagy and Mitophagy: Implications in Cancer Biology.
Lee S, Son J, Lee J, Cheong H
Cells. 2023; 12(23).
PMID: 38067169
PMC: 10706449.
DOI: 10.3390/cells12232742.
Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot-Marie-Tooth type 2A.
Rizzo F, Bono S, Ruepp M, Salani S, Ottoboni L, Abati E
Cell Mol Life Sci. 2023; 80(12):373.
PMID: 38007410
PMC: 10676309.
DOI: 10.1007/s00018-023-05018-w.
Targeting mitochondrial shape: at the heart of cardioprotection.
Hernandez-Resendiz S, Prakash A, Loo S, Semenzato M, Chinda K, Crespo-Avilan G
Basic Res Cardiol. 2023; 118(1):49.
PMID: 37955687
PMC: 10643419.
DOI: 10.1007/s00395-023-01019-9.
A human mitofusin 2 mutation can cause mitophagic cardiomyopathy.
Franco A, Li J, Kelly D, Hershberger R, Marian A, Lewis R
Elife. 2023; 12.
PMID: 37910431
PMC: 10619978.
DOI: 10.7554/eLife.84235.